Log in to save to my catalogue

NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality

NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6471005

NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality

About this item

Full title

NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2019-03, Vol.20 (6), p.1442

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Schizophrenia is a chronic mental disease, affecting around 1% of the general population. Schizophrenia is characterized by productive, negative, affective, and disorganization symptoms, and cognitive deficits. Cognitive deficits prevail in most of the schizophrenia patients and are one of the most disabling symptoms. They usually occur before the...

Alternative Titles

Full title

NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6471005

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6471005

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms20061442

How to access this item